Investment
Features
FeesSafety
Academy
More
Pluang+

Compare InMode Ltd (INMD) vs Kyndryl Holdings Inc (KD) Price & Performance

InMode LtdTrade
Kyndryl Holdings IncTrade

Price performance (Past 24H)

Key statistics

InMode Ltd vs Kyndryl Holdings Inc — how do they compare? InMode Ltd trades at $14.07 (market cap $806.05M), while Kyndryl Holdings Inc trades at $11.86 (market cap $2.49B). The key difference: Kyndryl Holdings Inc is far larger — about 3.1× InMode Ltd's market cap, and InMode Ltd is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 29 Days and Kyndryl Holdings Inc for 36 Days on average.

INMDKD
Market Cap
$806.05M$2.49B
Volume
511,4464,191,904
Sector
HealthTechnology
52-Week High
$16.62$29.76
52-Week Low
$12.76$10.59
Typical Hold Time
29 Days36 Days
Enterprise Value
$309.39M$5.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

InMode Ltd

INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.

The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.

Kyndryl Holdings Inc

Kyndryl Holdings (KD) trades at $11.45, down 0.26% on the day, with technical indicators showing bearish momentum. The company reported mixed quarterly results, missing Q4 2025 and Q1 2026 EPS estimates but beating in Q2 2026. Recent financials show improved profitability with 2025 net income of $252 million, though revenue has declined from $18.3B in 2022 to $15.1B in 2025. Analyst sentiment is cautious with a consensus 'Hold' rating and $14.67 price target, while institutional activity includes recent purchases by Virginia Retirement Systems.

KD presents a turnaround story with improving profitability but faces revenue headwinds and competitive pressures. The stock trades at reasonable valuation multiples (P/E 30.95, P/S 0.18) with positive cash flow generation. Key risks include ongoing revenue declines and high debt levels, while opportunities exist in AI initiatives and government contracts. The current technical weakness may present entry points for patient investors betting on management's execution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INMD

No sentiment data available yet.

KD
100% Buy0% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD →

About Kyndryl Holdings Inc

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.

Read more on KD →